• Pharma
  • April 24, 2025
  • 248 views
Novo Nordisk to phase out country’s largest insulin brand

In a move which could shake up the diabetes market, Novo Nordisk is discontinuing the country’s largest selling insulin, Human Mixtard, among other older insulin brands in India. Human Mixtard…

  • Pharma
  • March 19, 2025
  • 296 views
USV Joins Empagliflozin generic contest, launches its brand Xenia

New Delhi: One of India’s leading anti-diabetic players, USV, has become the latest entrant in the Empagliflozin generic contest with the launch of its version, Xenia, in India. The Indian drug maker…